Literature DB >> 25853370

Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels.

Anya K Bershad1, Matthew G Kirkpatrick, Jacob A Seiden, Harriet de Wit.   

Abstract

Many drugs, including alcohol and stimulants, demonstrably increase sociability and verbal interaction and are recreationally consumed in social settings. One drug, 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), seems to produce its prosocial effects by increasing plasma oxytocin levels, and the oxytocin system has been implicated in responses to several other drugs of abuse. Here, we sought to investigate the effects of 2 other "social" drugs on plasma oxytocin levels--methamphetamine and alcohol. Based on their shared capacity to enhance sociability, we hypothesized that both methamphetamine and alcohol would increase plasma oxytocin levels. In study 1, 11 healthy adult volunteers attended 3 sessions during which they received methamphetamine (10 mg or 20 mg) or placebo under double-blind conditions. Subjective drug effects, cardiovascular effects, and plasma oxytocin levels were measured at regular intervals throughout the sessions. In study 2, 8 healthy adult volunteers attended a single session during which they received 1 beverage containing placebo, and then a beverage containing alcohol (0.8 g/kg). Subjective effects, breath alcohol levels, and plasma oxytocin levels were measured at regular intervals. Both methamphetamine and alcohol produced their expected physiological and subjective effects, but neither of these drugs increased plasma oxytocin levels. The neurobiological mechanisms mediating the prosocial effects of drugs such as alcohol and methamphetamine remain to be identified.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25853370      PMCID: PMC4414800          DOI: 10.1097/JCP.0000000000000314

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  28 in total

1.  Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus.

Authors:  I D Neumann; A Wigger; L Torner; F Holsboer; R Landgraf
Journal:  J Neuroendocrinol       Date:  2000-03       Impact factor: 3.627

2.  Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

Authors:  W C Drevets; C Gautier; J C Price; D J Kupfer; P E Kinahan; A A Grace; J L Price; C A Mathis
Journal:  Biol Psychiatry       Date:  2001-01-15       Impact factor: 13.382

3.  Acute effects of 3,4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects.

Authors:  Julia Seibert; Cédric M Hysek; Carlos A Penno; Yasmin Schmid; Denise V Kratschmar; Matthias E Liechti; Alex Odermatt
Journal:  Neuroendocrinology       Date:  2014-06-05       Impact factor: 4.914

4.  MDMA enhances emotional empathy and prosocial behavior.

Authors:  Cédric M Hysek; Yasmin Schmid; Linda D Simmler; Gregor Domes; Markus Heinrichs; Christoph Eisenegger; Katrin H Preller; Boris B Quednow; Matthias E Liechti
Journal:  Soc Cogn Affect Neurosci       Date:  2013-10-04       Impact factor: 3.436

5.  Preliminary evidence for lowered basal cortisol in a naturalistic sample of methamphetamine polydrug users.

Authors:  Dean S Carson; David P Bosanquet; C Sue Carter; Hossein Pournajafi-Nazarloo; Alex Blaszczynski; Iain S McGregor
Journal:  Exp Clin Psychopharmacol       Date:  2012-10-15       Impact factor: 3.157

6.  In the company of others: social factors alter acute alcohol effects.

Authors:  Matthew G Kirkpatrick; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2013-05-28       Impact factor: 4.530

7.  Chronic methamphetamine treatment induces oxytocin receptor up-regulation in the amygdala and hypothalamus via an adenosine A2A receptor-independent mechanism.

Authors:  Panos Zanos; Sherie R Wright; Polymnia Georgiou; Ji Hoon Yoo; Catherine Ledent; Susanna M Hourani; Ian Kitchen; Raphaelle Winsky-Sommerer; Alexis Bailey
Journal:  Pharmacol Biochem Behav       Date:  2013-05-13       Impact factor: 3.533

8.  Differential effects of MDMA and methylphenidate on social cognition.

Authors:  Yasmin Schmid; Cédric M Hysek; Linda D Simmler; Molly J Crockett; Boris B Quednow; Matthias E Liechti
Journal:  J Psychopharmacol       Date:  2014-07-22       Impact factor: 4.153

9.  Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans.

Authors:  Matthew G Kirkpatrick; Sunday M Francis; Royce Lee; Harriet de Wit; Suma Jacob
Journal:  Psychoneuroendocrinology       Date:  2014-04-19       Impact factor: 4.905

10.  Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans.

Authors:  Nadine Striepens; Keith M Kendrick; Vanessa Hanking; Rainer Landgraf; Ullrich Wüllner; Wolfgang Maier; René Hurlemann
Journal:  Sci Rep       Date:  2013-12-06       Impact factor: 4.379

View more
  10 in total

1.  A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.

Authors:  Peter D Alexander; Kristina M Gicas; Taylor S Willi; Clara N Kim; Veronika Boyeva; Ric M Procyshyn; Geoff N Smith; Allen E Thornton; William J Panenka; Andrea A Jones; Fidel Vila-Rodriguez; Donna J Lang; G William MacEwan; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2017-02-11       Impact factor: 4.530

2.  Acute effects of lisdexamfetamine and D-amphetamine on social cognition and cognitive performance in a placebo-controlled study in healthy subjects.

Authors:  Patrick C Dolder; Petra Strajhar; Patrick Vizeli; Alex Odermatt; Matthias E Liechti
Journal:  Psychopharmacology (Berl)       Date:  2018-02-09       Impact factor: 4.530

3.  Alcohol acutely enhances decoding of positive emotions and emotional concern for positive stimuli and facilitates the viewing of sexual images.

Authors:  Patrick C Dolder; Friederike Holze; Evangelia Liakoni; Samuel Harder; Yasmin Schmid; Matthias E Liechti
Journal:  Psychopharmacology (Berl)       Date:  2016-09-19       Impact factor: 4.530

4.  Methamphetamine-alcohol interactions in murine models of sequential and simultaneous oral drug-taking.

Authors:  Elissa K Fultz; Douglas L Martin; Courtney N Hudson; Tod E Kippin; Karen K Szumlinski
Journal:  Drug Alcohol Depend       Date:  2017-05-24       Impact factor: 4.492

Review 5.  Considering the context: social factors in responses to drugs in humans.

Authors:  Harriet de Wit; Michael Sayette
Journal:  Psychopharmacology (Berl)       Date:  2018-02-22       Impact factor: 4.530

6.  Effects of MDMA on attention to positive social cues and pleasantness of affective touch.

Authors:  Anya K Bershad; Leah M Mayo; Kathryne Van Hedger; Francis McGlone; Susannah C Walker; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2019-04-30       Impact factor: 7.853

Review 7.  Alcohol and oxytocin: Scrutinizing the relationship.

Authors:  Andrey E Ryabinin; Hannah D Fulenwider
Journal:  Neurosci Biobehav Rev       Date:  2021-06-05       Impact factor: 9.052

8.  A prior history of binge-drinking increases sensitivity to the motivational valence of methamphetamine in female C57BL/6J mice.

Authors:  Kimberly R Sern; Elissa K Fultz; Michal A Coelho; Camron D Bryant; Karen K Szumlinski
Journal:  Subst Abuse       Date:  2020-01-20

9.  Beta-Endorphin and Oxytocin in Patients with Alcohol Use Disorder and Comorbid Depression.

Authors:  Olga V Roschina; Lyudmila A Levchuk; Anastasiia S Boiko; Ekaterina V Michalitskaya; Elena V Epimakhova; Innokentiy S Losenkov; German G Simutkin; Anton J M Loonen; Nikolay A Bokhan; Svetlana A Ivanova
Journal:  J Clin Med       Date:  2021-12-03       Impact factor: 4.241

Review 10.  The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?

Authors:  Anya K Bershad; Melissa A Miller; Matthew J Baggott; Harriet de Wit
Journal:  J Psychopharmacol       Date:  2016-08-25       Impact factor: 4.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.